Carrie Strom has been appointed senior vice president of U.S. medical aesthetics for Allergan, overseeing the company’s injectables, breast implant and beauty portfolio.
Most recently, Strom was vice president of marketing for plastic surgery and regenerative medicine at Allergan. She has also worked as vice president of marketing for SkinMedica. Strom reports to Bill Meury, Allergan’s chief commercial officer.
“Carrie will direct the entire commercial operation for U.S. medical aesthetics with a focus on ensuring that Allergan continues to develop and introduce new and innovative products and raise consumer awareness and interest for aesthetic treatments,” said Meury.
In her new role, Strom said her goal is to “grow the pie” and increase the number of consumers that use products in the portfolio. For Botox, for example, “the opportunity is to tap into all of the considerers,” Strom said.
The segment will also ramp up its digital outreach, she said. “We have a lot opportunity with digital to reach these potential consumers that aren’t necessarily actively in health-care providers offices,” Strom said. “But she is interested, she is considering, she is online, so that’s where a lot of our investment will be.”
You May Also Like
At Allergan’s skin-care brand, SkinMedica, the opportunity is also digital, Strom said. The brand launched e-commerce in fall 2017, and customers can now shop SkinMedica products through doctor web sites with two-day shipping.
SkinMedica’s business has slowed down in recent years — the business posted a 7.2 percent dip in sales for 2017 to $108.3 million — but Strom said part of that was cyclicality. The business is working on next-generation versions for cult products, including hero product TNS Essential Serum, she noted.
Strom said she plans to take a “humble” approach to the job — listening to customer feedback. “If we do what they need, it’s going to drive results for us,” she said.